Braveheart Bio, Inc.

Braveheart Bio, Inc.

NNASDAQ:BRVE
18.78
USD
-0.71
(-3.64%)
-1.10EPS
1.82BMarket Cap
Mar 03Next Earn

Braveheart Bio, Inc. Documents

Q1 FY2026 · Presentation

69c44322d48986d6cf92d183_Efficacy and Safety of BHB-1893 In Symptomatic oHCM (1) · 15 pages

Read Braveheart Bio, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q1 FY2026 documents